论文部分内容阅读
在最近发表于《Cell》的研究中,来自德州大学医学分校(UTMB)、范德堡大学、斯克里普斯研究所和Integral Molecular公司的合作研究团队发现,在一种埃博拉病毒株感染中幸存下来的人的血液中分离的抗体,能够杀死各种类型的埃博拉病毒。这些发现有助于研究人员进一步理解对埃博拉等病毒的免疫反应,可能导向对埃博拉病毒和其他相关病毒的治疗方法。埃博拉病毒感染的幸存者体内会发展出抗体。问题是,这些抗体能否对抗未来的埃博拉相关丝状病毒感染?尽管几种基于
In a recent study published in Cell, a collaborative research team from UTMB, Vanderbilt University, Scripps Research and Integral Molecular found that when an Ebola virus was infected Antibodies isolated from the blood of those surviving can kill various types of Ebola virus. These findings help researchers further understand the immune response to viruses such as Ebola and may lead to treatment of Ebola and other related viruses. Survivors of Ebola virus infection develop antibodies in vivo. The question is, can these antibodies fight future Ebola-related filamentous virus infections? Although several are based on